| 2024-04 |
Dysregulation of autophagy activation induced by atorvastatin contributes to new-onset diabetes mellitus in western diet-fed mice |
Metabolism: Clinical and Experimental
|
| 2024-03 |
Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study |
Metabolism: Clinical and Experimental
|
| 2024-02 |
Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as Metformin Add-on in a Korean Population with Type 2 Diabetes |
Diabetes Therapy
|
| 2024-01 |
Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes |
Frontiers in Endocrinology
|
| 2023-11 |
Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial |
Diabetes and Metabolism Journal
|
| 2023-10 |
Safety and Clinical Outcomes of Insulin Degludec in Korean Patients with Diabetes in Real-World Practices: A Prospective, Observational Study |
Diabetes Therapy
|
| 2023-10 |
Association between Impaired Ketogenesis and Metabolic-Associated Fatty Liver Disease |
Biomolecules
|
| 2023-09 |
MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study |
Journal of Gastroenterology and Hepatology
|
| 2023-09 |
Glucometabolic control of once-weekly dulaglutide switched from DPP4 inhibitor versus daily empagliflozin add-on in patients with type 2 diabetes inadequately controlled with metformin, sulfonylurea, and DPP4 inhibitor: A randomised trial |
DIABETES RESEARCH AND CLINICAL PRACTICE
|
| 2023-07 |
Significance of Diabetic Kidney Disease Biomarkers in Predicting Metabolic-Associated Fatty Liver Disease |
Biomedicines
|
| 2023-07 |
β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 6 months: Type 2 diabetes and β-hydroxybutyrate level |
Diabetes and Metabolism
|
| 2023-06 |
Efficacy of Gemigliptin Add-on to Dapagliflozin and Metformin in Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Study (SOLUTION) |
ENDOCRINOLOGY AND METABOLISM
|
| 2023-06 |
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial |
Nature Medicine
|
| 2023-06 |
Highly selective electrochemical quantitation of creatinine based on its chemical reaction with 3,5-dinitrobenzoate |
Journal of Electroanalytical Chemistry
|
| 2023-04 |
Age at Mortality in Patients with Type 2 Diabetes Who Underwent Kidney Transplantation: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018 |
Journal of Clinical Medicine
|
| 2023-02 |
Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes |
FRONTIERS IN ENDOCRINOLOGY
|
| 2022-09 |
Real-World Prescription Patterns and Barriers Related to the Use of Sodium-Glucose Cotransporter 2 Inhibitors among Korean Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease |
Diabetes and Metabolism Journal
|
| 2022-08 |
Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model |
ENDOCRINOLOGY AND METABOLISM
|
| 2022-08 |
The effects of the voglibose on non-alcoholic fatty liver disease in mice model |
SCIENTIFIC REPORTS
|
| 2022-06 |
Tolerability and Effectiveness of Switching to Dulaglutide in Patients with Type 2 Diabetes Inadequately Controlled with Insulin Therapy |
Frontiers in Endocrinology
|
| 2022-06 |
Improvement in Age at Mortality and Changes in Causes of Death in the Population with Diabetes: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018 |
Endocrinology and Metabolism
|
| 2022-06 |
Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes |
YONSEI MEDICAL JOURNAL
|
| 2022-06 |
Obesity is an important determinant of severity in newly defined metabolic dysfunction-associated fatty liver disease |
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
|
| 2022-06 |
Effectiveness and safety of teneligliptin added to patients with type 2 diabetes inadequately controlled by oral triple combination therapy: A multicentre, randomized, double-blind, and placebo-controlled study |
DIABETES OBESITY & METABOLISM
|
| 2022-04 |
Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21 |
FRONTIERS IN IMMUNOLOGY
|
| 2022-04 |
Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-based Cohort Study |
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
|
| 2022-04 |
Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial |
DIABETES OBESITY & METABOLISM
|
| 2022-03 |
Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease |
Gut and Liver
|
| 2022-03 |
Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease |
GUT AND LIVER
|
| 2022-03 |
Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study) |
BMC MEDICINE
|
| 2022-02 |
Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease |
Jama Network Open
|
| 2022-01 |
Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus |
Diabetes and Metabolism Journal
|
| 2021-12 |
Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes |
Frontiers in Cardiovascular Medicine
|
| 2021-11 |
Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetes |
DIABETES RESEARCH AND CLINICAL PRACTICE
|
| 2021-11 |
Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway |
Diabetes and Metabolism Journal
|
| 2021-07 |
2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea |
Diabetes and Metabolism Journal
|
| 2021-05 |
Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study |
Diabetes and Metabolism Journal
|
| 2021-04 |
Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes |
DIABETES OBESITY & METABOLISM
|
| 2021-03 |
Non-albumin proteinuira (MAP) as a complementary markder for diabetic kidney disease(DKD) |
Life-Basel
|
| 2021-02 |
Glycaemic control with add-on thiazolidinedione or a sodium-glucose co-transporter-2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24-week, randomized controlled trial |
DIABETES OBESITY & METABOLISM
|
| 2021-01 |
Age at diagnosis and the risk of diabetic nephropathy in young patients with type 1 diabetes mellitus |
Diabetes and Metabolism Journal
|
| 2020-12 |
Clinical outcomes of COVID-19 patients with type 2 diabetes: A population-based study in Korea |
Endocrinology and Metabolism
|
| 2020-11 |
Metformin and Gastrointestinal Cancer Development in Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea |
Clinical and Translational Gastroenterology
|
| 2020-11 |
Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
|
| 2020-10 |
Efficacy and Tolerability of Pitavastatin Versus Pitavastatin/Fenofibrate in High-risk Korean Patients with Mixed Dyslipidemia: A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial |
CLINICAL THERAPEUTICS
|
| 2020-10 |
Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression |
SCIENTIFIC REPORTS
|
| 2020-10 |
Data Configuration and Publication Trends for the Korean National Health Insurance and Health Insurance Review & Assessment Database |
Diabetes and Metabolism Journal
|
| 2020-10 |
Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease |
Clinical and molecular hepatology
|
| 2020-08 |
Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes |
MEDICINE
|
| 2020-06 |
Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association |
Diabetes and Metabolism Journal
|
| 2020-06 |
Nonalcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes a Korean cohort study |
CARDIOVASCULAR DIABETOLOGY
|
| 2020-05 |
SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease |
NATURE COMMUNICATIONS
|
| 2020-04 |
Gamma glutamyltransferase and risk of dementia in prediabetes and diabetes |
SCIENTIFIC REPORTS
|
| 2020-04 |
Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus |
Diabetes and Metabolism Journal
|
| 2020-04 |
Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk |
AMERICAN JOURNAL OF GASTROENTEROLOGY
|
| 2020-03 |
Comparison of Renal Effects of Ezetimibe-Statin Combination versus Statin Monotherapy: A Propensity-Score-Matched Analysis |
Journal of Clinical Medicine
|
| 2020-01 |
Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 DiabetesControlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial |
Journal of Clinical Medicine
|
| 2020-01 |
Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes |
Journal of Lipid and Atherosclerosis
|
| 2020-01 |
Proteinuria is Associated with Carotid Artery Atherosclerosis in Non-Albuminuric Type 2 Diabetes: A Cross-Sectional Study |
Journal of Clinical Medicine
|
| 2019-12 |
A Lower Baseline Urinary Glucose Excretion Predicts a Better Response to the Sodium Glucose Cotransporter 2 Inhibitor |
Diabetes and Metabolism Journal
|
| 2019-12 |
Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus |
TRANSPLANTATION PROCEEDINGS
|
| 2019-10 |
The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis |
Journal of Clinical Medicine
|
| 2019-09 |
Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea |
Endocrinology and Metabolism
|
| 2019-08 |
Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea |
Diabetes and Metabolism Journal
|
| 2019-08 |
Glucometabolic characteristics and higher vascular complication risk in Korean patients with type 2 diabetes with non-albumin proteinuria |
JOURNAL OF DIABETES AND ITS COMPLICATIONS
|
| 2019-08 |
Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors |
CANCER CHEMOTHERAPY AND PHARMACOLOGY
|
| 2019-07 |
Risk of Incident Dementia According to Metabolic Health and Obesity Status in Late Life: A Population-Based Cohort Study |
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
|
| 2019-06 |
Effectiveness of Exercise Intervention in Reducing Body Weight and Glycosylated Hemoglobin Levels in Patients with Type 2 Diabetes Mellitus in Korea: A Systematic Review and Meta-Analysis |
Diabetes and Metabolism Journal
|
| 2019-05 |
Spontaneous ketonuria and risk of incident diabetes: a 12 year prospective study |
DIABETOLOGIA
|
| 2019-04 |
Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment |
Diabetes and Metabolism Journal
|
| 2019-04 |
Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors |
Diabetes and Metabolism Journal
|
| 2019-04 |
Sodium-glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter-organ crosstalk |
DIABETES OBESITY & METABOLISM
|
| 2019-03 |
Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus. |
SCIENTIFIC REPORTS
|
| 2019-03 |
Association between nonalbumin proteinuria and renal tubular damage of N-acetyl-β-D-glucosaminidase and its clinical relevance in patients with type 2 diabetes without albuminuria |
JOURNAL OF DIABETES AND ITS COMPLICATIONS
|
| 2019-02 |
Differential effects of thiazolidinediones and dipeptidyl peptidase-4 inhibitors on insulin resistance and b-cell function in type 2 diabetes mellitus: A propensity score-matched analysis |
DIABETES THERAPY
|
| 2019-02 |
Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis |
Diabetes and Metabolism Journal
|
| 2019-01 |
Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide |
DIABETES & METABOLISM
|
| 2018-11 |
Relationship Between Circulating Netrin-1 Concentration, Impaired Fasting Glucose, and Newly Diagnosed Type 2 Diabetes |
Frontiers in Endocrinology
|
| 2018-11 |
Clinical efficacy of the novel thiazolidinedione lobeglitazone in patients with type 2 diabetes |
DIABETES & METABOLISM
|
| 2018-09 |
The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition |
Frontiers in Endocrinology
|
| 2018-08 |
Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea |
DIABETES THERAPY
|
| 2018-08 |
Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B |
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
|
| 2018-08 |
Elevated N-acetyl-beta-D-glucosaminidase, a urinary tubular damage marker, is a significant predictor of carotid artery atherosclerosis in type 1 diabetes, independent of albuminuria: A cross-sectional study |
JOURNAL OF DIABETES AND ITS COMPLICATIONS
|
| 2018-08 |
Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study |
SCIENTIFIC REPORTS
|
| 2018-07 |
Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea |
THYROID
|
| 2018-07 |
Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus |
Frontiers in Endocrinology
|
| 2018-06 |
Glycated Albumin Is a More Useful Glycation Index than HbA1c for Reflecting Renal Tubulopathy in Subjects with Early Diabetic Kidney Disease |
Diabetes and Metabolism Journal
|
| 2018-06 |
Fasting serum amino acids concentration is associated with insulin resistance and pro-inflammatory cytokines |
DIABETES RESEARCH AND CLINICAL PRACTICE
|
| 2018-06 |
Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis |
대한내분비학회지
|
| 2018-06 |
The Association Between Low 50 g Glucose Challenge Test Values and Adverse Pregnancy Outcomes. |
JOURNAL OF WOMENS HEALTH
|
| 2018-05 |
Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2018-04 |
Elevated urinary N-Acetyl-β-D-glucosaminidase is associated with high glycoalbumin-To-hemoglobin A1c ratio in type 1 diabetes patients with early diabetic kidney disease |
SCIENTIFIC REPORTS
|
| 2018-04 |
Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients |
JOURNAL OF HEPATOLOGY
|
| 2018-03 |
Effects of lobeglitazone, a novel thiazolidinedione, on adipose tissue remodeling and brown and beige adipose tissue development in db/db mice |
INTERNATIONAL JOURNAL OF OBESITY
|